AI Toolkit

AI Toolkit is a product from VML Health Platforms Hub designed to help pharmaceutical and healthcare organisations build and enhance internal AI platforms for Medical Affairs. It provides validated, modular AI capabilities that can serve as building blocks for an in-house platform, addressing challenges around data security, compliance, medical accuracy, and the pace of AI development.

The toolkit is aimed at Medical Affairs teams that want to bring AI capabilities in-house rather than relying solely on external agencies, while still benefiting from specialist technical and pharma expertise. VML positions itself as a long-term technology partner with over a decade of dedicated pharmaceutical and healthcare focus.

Benefits of Building an In-House AI Platform

• Accelerates innovation and reduces time-to-market for AI-driven capabilities
• Reduces internal and agency costs
• Keeps data secure and innovations private
• Allows customisation to suit specific organisational needs
• Safeguards strategic advantage by retaining control over data and workflows

Challenges Addressed

• Ensuring the platform utilises current and evolving AI capabilities
• Maintaining compliance and robustness, particularly around medical accuracy
• Keeping pace with the rapid development of AI technologies
• Continually evolving the platform to match available tools and techniques

AI Toolkit Building Blocks

• Real-time Insights: extracts value from field data instantly
• Rapid Answers: answers Key Information Questions (KIQs) and Key Information Topics (KITs) on the fly
• Effortless Reporting: transforms HCP transcripts into actionable reports
• Trend Spotting: triangulates key insights across all data domains
• Voice of Customer: surfaces key headlines from customer feedback
• Signal Detection: identifies previously unseen signals instantly
• Strategic Alignment: automatically identifies actions that support organisational goals
• Unearth The Story: interprets the narrative within data sets

Platform Capabilities and Outcomes

• Supports scientific exchange, engagement, and insight generation through AI-driven tools
• Unlocks actionable intelligence from real-world data and automates repetitive processes
• Enables deeper collaboration across regulatory, medical, and commercial functions
• Provides intelligent search, real-time analytics, and customised reporting
• Integrates the latest medical accuracy models and techniques
• Custom-built to support unique workflows and asset types
• Ongoing updates keep the platform current with AI innovation, supported by VML technical, medical, and data specialists

Implementation Pathways

• Advisory and design support: VML shares experience to help organisations design and build an in-house AI platform, drawing on lessons from other pharmaceutical implementations
• White label integration: AI capabilities can be integrated at specific points within an existing platform to create a consistent user experience
• Custom build and data integration: support for specific build requirements, data integration, and workflows — including AI-led curation of multi-channel data for single-view content analysis and custom AI-driven workflows that supplement existing internal platforms

VML is a WPP company with 30,000 employees globally, including 10,000 technologists across 30 countries. The platforms are described as future-proof, with continuous improvement, ongoing support, and scalable integration. All implementations are designed to keep data, innovations, and strategy under the client organisation's control.